Skip to main content
. 2010 Jul 13;103(3):303–309. doi: 10.1038/sj.bjc.6605778

Figure 2.

Figure 2

(A) The ROC curve for risk-factor model score and the presence of OPMD (except lichen planus) in Phase 2 validation study. (B) The ROC curve for risk-factor model score and the presence of all oral mucosal disorders in Phase 2 validation study.